Answers are grounded in this paper and cite their sources.
This cohort study examines neutralizing antibodies against the SARS-CoV-2 Omicron variant (BA.1) after the second and third doses of the BNT162b2 mRNA vaccine among Danish adults.
No takes yet. Share an insight, caveat, or question.
Lassaunière et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: